This Article Full Text Full Text (PDF) Other Versions of this Article: AAC.01506-07v1 52/6/2169    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Salát, J. Articles by Kopecky, J. Search for Related Content PubMed PubMed Citation Articles by Salát, J. Articles by Kopecky, J.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, June 2008, p. 2169-2174, Vol. 52, No. 6
0066-4804/08/$08.00+0     doi:10.1128/AAC.01506-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Efficacy of Gamma Interferon and Specific Antibody for Treatment of Microsporidiosis Caused by Encephalitozoon cuniculi in SCID Mice

Jií Salát,^* Jií Jelínek, Jindich Chmela, and Jan Kopeck

Biology Centre Academy of Sciences of the Czech Republic, Institute of Parasitology and Faculty of Biological Sciences, University of South Bohemia, eské Budjovice, Czech Republic

Received 20 November 2007/ Returned for modification 19 December 2007/ Accepted 11 March 2008

Microsporidia are eukaryotic, obligate, intracellular protists that are emerging pathogens in immunocompromised hosts, including AIDS patients and organ transplant recipients. The efficacy of gamma interferon (IFN-) for the treatment of microsporidiosis caused by Encephalitozoon cuniculi was studied by means of adoptive transfer and IFN- administration in SCID mice. While the adoptive transfer of CD4⁺ T cells from immunocompetent mice prolonged survival of SCID mice infected perorally with E. cuniculi, survival was not improved by adoptive transfer of CD4⁺ T lymphocytes from IFN--deficient mice. The protective effect of IFN- was confirmed in cytokine therapy experiments in which SCID mice receiving IFN- survived significantly longer than mice receiving mock injections. The administration of serum containing specific antibodies against E. cuniculi was found to prolong the survival of concurrently IFN--treated SCID mice. The data presented in this study suggest that IFN- is potentially useful as a cytokine therapy for microsporidiosis, especially in CD4⁺ T-cell-deficient patients.

Published ahead of print on 17 March 2008.